DBV Technologies S.A.

DBVTNasdaq· Biological Products, (No Diagnostic Substances)

Price History

Revenue

$4.2M

▼ 73.6% YoY

Net Income

-$113.9M

▼ 56.6% YoY

EPS

$-1.17

▼ 53.9% YoY

Cash

$32.5M

▼ 77.0% YoY

FY 2024 · As of 2024-12-31

Pro

10-K Year-over-Year Diff

AI-powered analysis of what changed between the last two annual reports — new risks, removed language, strategy shifts.